Hemo Organic Capital Structure Change
Hemo Organic's board approved increasing authorised share capital to Rs. 125 Crore and amended the main objects clause to include diamond and real estate business activities.
ALFA Filings
Every announcement, straight from the exchange
Every Hemo Organic capital structure change announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Hemo Organic's board approved increasing authorised share capital to Rs. 125 Crore and amended the main objects clause to include diamond and real estate business activities.
Hemo Organic Ltd allotted 34 lakh equity shares upon conversion of warrants to non-promoter entities. The company received Rs. 3.1875 Crore as the balance consideration.
Non-promoter Dharmendrabhai Becharbhai Jasani acquired 1,11,341 shares of Hemo Organic Ltd via on-market purchase, increasing his stake in the company.
Hemo Organic Ltd received the 2nd tranche of consideration worth ₹2.76 Crore for convertible warrants from non-promoter allottees, progressing towards future equity share conversion.